Artigo Revisado por pares

Effect of Immunization with Inactivated gp120-Depleted Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen on HIV-1 Immunity, Viral DNA, and Percentage of CD4 Cells

1994; Oxford University Press; Volume: 169; Issue: 6 Linguagem: Inglês

10.1093/infdis/169.6.1256

ISSN

1537-6613

Autores

Richard Trauger, F. Ferré, Anne E. Daigle, Fred C. Jensen, Richard B. Moss, Stefanie Mueller, Steven P. Richieri, Herbert B. Slade, Dennis J. Carlo,

Tópico(s)

HIV/AIDS drug development and treatment

Resumo

Journal Article Effect of Immunization with Inactivated gp120-Depleted Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen on HIV-1 Immunity, Viral DNA, and Percentage of CD4 Cells Get access Richard J. Trauger, Richard J. Trauger Immune Response Corporation, Carlsbad, California; Immunization Products Limited and Rhone-Poulenc Rorer Inc., Collegeville, Pennsylvania Reprints or correspondence: Dr. Richard J. Trauger, Immune Response Corp., 5935 Darwin Ct., Carlsbad, CA 92008. Search for other works by this author on: Oxford Academic PubMed Google Scholar Francois Ferre, Francois Ferre Immune Response Corporation, Carlsbad, California; Immunization Products Limited and Rhone-Poulenc Rorer Inc., Collegeville, Pennsylvania Search for other works by this author on: Oxford Academic PubMed Google Scholar Anne E. Daigle, Anne E. Daigle Immune Response Corporation, Carlsbad, California; Immunization Products Limited and Rhone-Poulenc Rorer Inc., Collegeville, Pennsylvania Search for other works by this author on: Oxford Academic PubMed Google Scholar Fred C. Jensen, Fred C. Jensen Immune Response Corporation, Carlsbad, California; Immunization Products Limited and Rhone-Poulenc Rorer Inc., Collegeville, Pennsylvania Search for other works by this author on: Oxford Academic PubMed Google Scholar Ronald B. Moss, Ronald B. Moss Immune Response Corporation, Carlsbad, California; Immunization Products Limited and Rhone-Poulenc Rorer Inc., Collegeville, Pennsylvania Search for other works by this author on: Oxford Academic PubMed Google Scholar Stewart H. Mueller, Stewart H. Mueller Immune Response Corporation, Carlsbad, California; Immunization Products Limited and Rhone-Poulenc Rorer Inc., Collegeville, Pennsylvania Search for other works by this author on: Oxford Academic PubMed Google Scholar Steven P. Richieri, Steven P. Richieri Immune Response Corporation, Carlsbad, California; Immunization Products Limited and Rhone-Poulenc Rorer Inc., Collegeville, Pennsylvania Search for other works by this author on: Oxford Academic PubMed Google Scholar Herbert B. Slade, Herbert B. Slade Immune Response Corporation, Carlsbad, California; Immunization Products Limited and Rhone-Poulenc Rorer Inc., Collegeville, Pennsylvania Search for other works by this author on: Oxford Academic PubMed Google Scholar Dennis J. Carlo Dennis J. Carlo Immune Response Corporation, Carlsbad, California; Immunization Products Limited and Rhone-Poulenc Rorer Inc., Collegeville, Pennsylvania Search for other works by this author on: Oxford Academic PubMed Google Scholar The Journal of Infectious Diseases, Volume 169, Issue 6, June 1994, Pages 1256–1264, https://doi.org/10.1093/infdis/169.6.1256 Published: 01 June 1994 Article history Received: 27 September 1993 Revision received: 28 December 1993 Published: 01 June 1994

Referência(s)